Eva Ludwig-Schwellinger

The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans

Stefan Blech, Thomas Ebner, Eva Ludwig-Schwellinger et al. · Drug Metabolism and Disposition · 2007 · 676 citations

Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities

Sumio Ohtsuki, Olaf Schaefer, Hirotaka Kawakami et al. · Drug Metabolism and Disposition · 2011 · 428 citations

The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans

Stefan Blech, Eva Ludwig-Schwellinger, Eva Ulrike Gräfe-Mody et al. · Drug Metabolism and Disposition · 2010 · 187 citations

Hepatic differentiation of human iPSCs in different 3D models: A comparative study

Florian Meier, Nora Freyer, Joanna Brzeszczyńska et al. · International Journal of Molecular Medicine · 2017 · 58 citations · Full text

Tissue Engineering, Cell Culture, Biomedical Engineering +25

In Vitro Predictability of Drug-Drug Interaction Likelihood of P-Glycoprotein-Mediated Efflux of Dabigatran Etexilate Based on [I]2/IC50 Threshold

Wataru Kishimoto, Naoki Ishiguro, Eva Ludwig-Schwellinger et al. · Drug Metabolism and Disposition · 2013 · 55 citations